The role of pancreatic imaging in monogenic diabetes mellitus (Q37962349)

26 August 2017

The role of pancreatic imaging in monogenic diabetes mellitus (English)

1 reference

26 August 2017

1

1 reference

26 August 2017

5

Pål R Njølstad

1 reference

26 August 2017

4

Anders Molven

1 reference

26 August 2017

Helge Ræder

2

1 reference

PubMed ID

22124438

26 August 2017

Mette Vesterhus

series ordinal

3

1 reference

26 August 2017

29 November 2011

1 reference

Nature Reviews Endocrinology

26 August 2017

1 reference

26 August 2017

8

1 reference

26 August 2017

3

1 reference

26 August 2017

148-159

1 reference

https://scigraph.springernature.com/pub.10.1038/nrendo.2011.197

26 August 2017

0 references

cites work

The diagnosis and management of monogenic diabetes in children and adolescents

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

MODY: history, genetics, pathophysiology, and clinical decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Neonatal hyperglycaemia and abnormal development of the pancreas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Prevalence of monogenic diabetes in young adults: a community-based, cross-sectional study in Oxfordshire, UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Mutations in PTF1A cause pancreatic and cerebellar agenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Disorders of the pediatric pancreas: imaging features

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Imaging the pancreas: into the deep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Incidence and diagnostic significance of minor pathologic changes in the adult pancreas at autopsy: a systematic study of 112 autopsies in patients without known pancreatic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Size of pancreas in children and adolescents with type I (insulin-dependent) diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

The size of the pancreas in diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Noninvasive imaging of pancreatic islet inflammation in type 1A diabetes patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Reduced pancreatic volume in hepatocyte nuclear factor 1A-maturity-onset diabetes of the young.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Pancreatic volume associated with endocrine and exocrine function of the pancreas among Japanese alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

MRI and MRCP findings of the pancreas in patients with diabetes mellitus: compared analysis with pancreatic exocrine function determined by fecal elastase 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Nonalcoholic, nonbiliary pancreatitis: cross-sectional imaging spectrum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Radiologic assessment of acute and chronic pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Obesity and fat quantification in lean tissues using three-point Dixon MR imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Pancreatic fat content and beta-cell function in men with and without type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

The clinical significance of pancreatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

The generalized aminoaciduria seen in patients with hepatocyte nuclear factor-1alpha mutations is a feature of all patients with diabetes and is associated with glucosuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Recent advances in the genetics of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Hepatocyte nuclear factor-1 beta mutations cause neonatal diabetes and intrauterine growth retardation: support for a critical role of HNF-1? in human pancreatic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Neonatal Diabetes Mellitus and Neonatal Polycystic, Dysplastic Kidneys: Phenotypically Discordant Recurrence of a Mutation in the Hepatocyte Nuclear Factor-1β Gene Due to Germline Mosaicism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Lack of TCF2/vHNF1 in mice leads to pancreas agenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Beta-cell growth and regeneration: replication is only part of the story

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Fat quantification using three-point dixon technique: in vitro validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Autosomal inheritance of diabetes in two families characterized by obesity and a novel H241Q mutation in NEUROD1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

MODY7 gene, KLF11, is a novel p300-dependent regulator of Pdx-1 (MODY4) transcription in pancreatic islet beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

PAX4 mutations in Thais with maturity onset diabetes of the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

A missense mutation of Pax4 gene (R121W) is associated with type 2 diabetes in Japanese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Mutations in the insulin gene can cause MODY and autoantibody-negative type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Mutations at the BLK locus linked to maturity onset diabetes of the young and beta-cell dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Long-term course of neonatal diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Aetiopathology and genetic basis of neonatal diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Origin of de novo KCNJ11 mutations and risk of neonatal diabetes for subsequent siblings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Update in neonatal diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Permanent neonatal diabetes mellitus: clinical presentation and epidemiology in Oman

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Insulin gene mutations as a cause of permanent neonatal diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early infancy: a report from the French ND (Neonatal Diabetes) Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Transient neonatal diabetes, a disorder of imprinting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Neonatal diabetes mellitus with pancreatic agenesis in an infant with homozygous IPF-1 Pro63fsX60 mutation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Agenesis of human pancreas due to decreased half-life of insulin promoter factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

A novel hypomorphic PDX1 mutation responsible for permanent neonatal diabetes with subclinical exocrine deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X linked (IPEX) syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Rfx6 directs islet formation and insulin production in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Neonatal diabetes, with hypoplastic pancreas, intestinal atresia and gall bladder hypoplasia: search for the aetiology of a new autosomal recessive syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Novel GLIS3 mutations demonstrate an extended multisystem phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Diabetes and pancreatic exocrine dysfunction due to mutations in the carboxyl ester lipase gene-maturity onset diabetes of the young (CEL-MODY): a protein misfolding disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Pancreatic fat is negatively associated with insulin secretion in individuals with impaired fasting glucose and/or impaired glucose tolerance: a nuclear magnetic resonance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

A case of Johanson-Blizzard syndrome complicated by diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Shwachman-Diamond syndrome: a review of the clinical presentation, molecular pathogenesis, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Update on cystic fibrosis-related diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

The genetic basis of congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Rare forms of congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

The spectrum of ABCC8 mutations in Norwegian patients with congenital hyperinsulinism of infancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

[18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Diagnostic accuracy of [¹⁸F]-fluoro-L-dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Positron emission tomography/computed tomography diagnostics by means of fluorine-18-L-dihydroxyphenylalanine in congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

The predictive value of preoperative fluorine-18-L-3,4-dihydroxyphenylalanine positron emission tomography-computed tomography scans in children with congenital hyperinsulinism of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

A point mutation inactivating the sulfonylurea receptor causes the severe form of persistent hyperinsulinemic hypoglycemia of infancy in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Genetic heterogeneity in familial hyperinsulinism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Towards high resolution optical imaging of beta cells in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Approaches for imaging islets: recent advances and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Development of radiotracers for the determination of the beta-cell mass in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

MRI as a tool to monitor islet transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

VMAT2 quantitation by PET as a biomarker for beta-cell mass in health and disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

In vivo beta-cell imaging with VMAT 2 ligands--current state-of-the-art and future perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

MRI in diabetes: first results

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Pancreatic perfusion of healthy individuals and type 1 diabetic patients as assessed by magnetic resonance perfusion imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Diffusion-weighted magnetic resonance imaging of the pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Comparison of fat-water MRI and single-voxel MRS in the assessment of hepatic and pancreatic fat fractions in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Hepatic function in a family with a nonsense mutation (R154X) in the hepatocyte nuclear factor-4alpha/MODY1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

A large multi-centre European study validates high-sensitivity C-reactive protein (hsCRP) as a clinical biomarker for the diagnosis of diabetes subtypes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

High-sensitivity CRP discriminates HNF1A-MODY from other subtypes of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Diagnosis and treatment of neonatal diabetes: a United States experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Activating mutations in the ABCC8 gene in neonatal diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Permanent diabetes during the first year of life: multiple gene screening in 54 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Wolfram syndrome and WFS1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Prevalence ofHNF1A(MODY3) mutations in a Norwegian population (the HUNT2 Study)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Maturity-onset diabetes of the young (MODY): how many cases are we missing?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Role of molecular genetics in transforming diagnosis of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Lack of pancreatic body and tail in HNF1B mutation carriers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Pancreatic lipomatosis is a structural marker in nondiabetic children with mutations in carboxyl-ester lipase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Residual insulin positivity and pancreatic atrophy in relation to duration of chronic Type 1 (insulin-dependent) diabetes mellitus and microangiopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Pancreatic volume in type 1 and type 2 diabetes mellitus

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Magnetic resonance imaging: a reliable method for measuring pancreatic volume in Type 1 diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

The density, contour, and thickness of the pancreas in diabetics: CT findings in 57 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Spectrum of causes of pancreatic calcifications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Morphologic changes in the pancreas detected by screening ultrasonography in a mass survey, with special reference to main duct dilatation, cyst formation, and calcification.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Pancreas and aging: a study using ultrasonography

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Neonatal hyperinsulinaemic hypoglycaemia and monogenic diabetes due to a heterozygous mutation of the HNF4A gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

HNF1B mutation in a Turkish child with renal and exocrine pancreas insufficiency, diabetes and liver disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Early-onset type-II diabetes mellitus (MODY4) linked to IPF1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

The insulin-pancreatic acinar axis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Why are the islets of Langerhans?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

A specialized team approach to diagnosis and medical versus surgical treatment of infants with congenital hyperinsulinism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Beta cell imaging--why we need it and what has been achieved

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Clinical magnetic resonance imaging of pancreatic islet grafts after iron nanoparticle labeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

WFS1 mutations are frequent monogenic causes of juvenile-onset diabetes mellitus in Lebanon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRENDO.2011.197

Non-invasive in vivo imaging of pancreatic β-cell function and survival - a perspective

31 March 2020

1 reference

12 December 2020

Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography.

1 reference

12 December 2020

Are ultrasonic images in diabetics different?

1 reference

12 December 2020

Recent advances and novel methods in pancreatic imaging

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRENDO.2011.197

1 reference

PubMed ID

22124438

Dimensions Publication ID

26 August 2017

0 references

1 reference

PubMed ID

22124438